Literature DB >> 18505391

Miconazole revisited: new evidence of antifungal efficacy from laboratory and clinical trials.

Andrei Barasch1, Andreea Voinea Griffin.   

Abstract

In the past 40 years imidazoles have been used extensively in medicine for their antifungal properties. All members of the azole antifungal family inhibit ergosterol biosynthesis. However, the discovery of an additional fungicidal mode of action for miconazole has drawn renewed attention to this compound. In this article we review recent evidence of mechanistic efficacy, as well as clinical trial results of miconazole in new topical formulations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18505391     DOI: 10.2217/17460913.3.3.265

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  3 in total

1.  Miconazole induces fungistasis and increases killing of Candida albicans subjected to photodynamic therapy.

Authors:  Sara B Snell; Thomas H Foster; Constantine G Haidaris
Journal:  Photochem Photobiol       Date:  2011-12-20       Impact factor: 3.421

2.  Susceptibilities of Candida albicans mouth isolates to antifungal agents, essentials oils and mouth rinses.

Authors:  Sara Carvalhinho; Ana Margarida Costa; Ana Cláudia Coelho; Eugénio Martins; Ana Sampaio
Journal:  Mycopathologia       Date:  2012-01-14       Impact factor: 2.574

Review 3.  Emerging Trends in the Use of Topical Antifungal-Corticosteroid Combinations.

Authors:  Dalibor Mijaljica; Fabrizio Spada; Ian P Harrison
Journal:  J Fungi (Basel)       Date:  2022-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.